<DOC>
	<DOCNO>NCT00536913</DOCNO>
	<brief_summary>The purpose study compare Symbicort pMDI without spacer term steroid potency , improvement lung function asthma symptom child asthma ( 6-11 year ) .</brief_summary>
	<brief_title>Evaluation Safety Efficacy SymbicortÂ® pMDI , With Without Spacer , Children ( 6-11 Years ) With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>child 611 year , diagnose asthma treat 6 month , PEF 50 % predict normal value prebronchodilator current systemic glucocorticosteroids usage current respiratory infection significant disease disorder judge investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Symbicort pMDI</keyword>
	<keyword>spacer</keyword>
	<keyword>child</keyword>
</DOC>